Project Grant W81XWH2211123

PREVENT Study Federal Grant Award Summary Emory University has received a $1,229,954 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2028. The award funds the PREVENT Study: Promoting Resilience via Early Neurostimulation After Trauma, a clinical research initiative designed to prevent chronic post-traumatic stress disorder (PTSD) and depression in trauma survivors by targeting...

Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Vanderbilt University Medical Center a $185,578 Project Grant on September 25, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the Mode of Ventilation During Critical Illness at Multiple Centers (MODEM) Trial through July 31, 2030. Principal Investigator Dr. Kevin P. Seitz, an instructor in the Division of Allergy, Pulmonary, and Critical Care Medicine at Vanderbilt, will...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $6,522,833 Project Grant to The Leland Stanford Junior University to conduct a mechanistic randomized clinical trial investigating the central and peripheral nervous system mechanisms of pain relief induced by peripheral nerve stimulation (PNS) for the treatment of refractory chronic neuropathic pain. The 3-year study, funded under the NIH HEAL Initiative's CFDA 93.279 Drug Abuse and Addiction Research Programs, aims...

Federal Project Grant Summary The Pediatric Prehospital Ventilation Trial (PEDI-VENT), funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), is an ancillary study designed to analyze optimal ventilation strategies for critically ill and injured children in emergency medical services (EMS) settings. Awarded to Oregon Health & Science University on September 19, 2025, with $1,632,238 obligated through June 30, 2029,...

This federal Cooperative Agreement award, totaling $1,594,319.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas Health Science Center at Houston (UTHealth). The award aims to develop and test an innovative, non-invasive device called Breathing-Controlled Electrical Stimulation (BREESTIM) for the management of neuropathic pain after spinal cord injury. The project...

WINDSURFER Trial Cooperative Agreement Summary The Ohio State University received a $1,535,439 Cooperative Agreement award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with completion targeted for August 31, 2026. The primary deliverable is the WINDSURFER (WIN Ratio Analysis to Determine a Strategy of Non-Invasive Support for Respiratory Failure in the Emergency Department) clinical...

The National Institute of Mental Health awarded Evren Technologies, Inc. a $769,743 project grant under the Mental Health Research Grants program (CFDA 93.242) to develop a personalized transcutaneous vagal nerve stimulation device for post-traumatic stress disorder research and treatment. Evren will create the Phoenix Laboratory, the first non-invasive vagal nerve stimulator designed to meet the complex needs of both researchers and patients. In Phase I, Evren will develop the stimulator and...

This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...

The Spinex Inc. was awarded a $4,719,091 Project Grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to develop and clinically validate a transcutaneous electrical spinal cord neuromodulation (TESCON) device to mitigate symptoms of neurogenic bladder resulting from spinal cord injury. The award, made under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support Spinex in building a commercial...

Summary RTI International (Research Triangle Institute) received a Cooperative Agreement award of $805,722 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 6, 2025, with a completion date of July 31, 2030. The award funds the "Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)," a clinical research initiative addressing...